| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2006 | EP1615670A2 Targets for tumor growth inhibition |
| 01/18/2006 | EP1615664A1 Pharmaceutical composition for treatment of immunological disorders |
| 01/18/2006 | EP1615663A1 Agent for treating leishmania infections |
| 01/18/2006 | EP1615661A2 Tumor antigens bfa5 for prevention and/or treatment of cancer |
| 01/18/2006 | EP1615656A2 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 01/18/2006 | EP1615653A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 01/18/2006 | EP1615610A2 Inhibitors of coronavirus |
| 01/18/2006 | EP1615494A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene |
| 01/18/2006 | EP1615493A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 01/18/2006 | EP1539816B1 Thrombin-cleavable factor x analogues |
| 01/18/2006 | EP1513559A4 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system |
| 01/18/2006 | EP1512016B1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/18/2006 | EP1511760B1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/18/2006 | EP1503780A4 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth |
| 01/18/2006 | EP1307214A4 Highly homogeneous molecular markers for electrophoresis |
| 01/18/2006 | EP1252181B1 Peptides with antibacterial activity |
| 01/18/2006 | EP1232183B1 Peptides having antiangiogenic activity |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/18/2006 | EP1100925B1 Attenuated equine herpesvirus |
| 01/18/2006 | EP1071442B9 Methods and compositions for peptide synthesis (t-20) |
| 01/18/2006 | EP1038010B1 Gram-positive microorganism formate transporters |
| 01/18/2006 | EP1015483B1 Malaria polypeptides |
| 01/18/2006 | EP0994722B1 Method of removing endotoxin from vaccines |
| 01/18/2006 | EP0915910B1 Exendin analogues, processes for their preparation and medicaments containing them |
| 01/18/2006 | EP0882129B1 Recombinant expression of s-layer proteins |
| 01/18/2006 | EP0836707B1 Improved hapten-peptide conjugates to detect anti-hiv-1 or anti-hiv-2 antibodies |
| 01/18/2006 | EP0815197B1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723391A Oligopeptides for promoting hair growth |
| 01/18/2006 | CN1723284A Regulatory zinc finger proteins |
| 01/18/2006 | CN1723283A Method for manufacturing recombinant polyclonal proteins |
| 01/18/2006 | CN1723282A Protein complex, process for producing the same and use thereof |
| 01/18/2006 | CN1723280A Gene improving temperature-tolerance of acetic acid bacterium, acetic acid bacterium bred using the gene and process for producing vinegar using the acetic acid bacterium |
| 01/18/2006 | CN1723035A Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 01/18/2006 | CN1723034A Composition and method for treating diabetes |
| 01/18/2006 | CN1723032A Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 01/18/2006 | CN1721537A Gene encoding protease inhibitor and encoded protein thereby |
| 01/18/2006 | CN1721536A Plant-disease-resistance related protein and genes encoding same and use thereof |
| 01/18/2006 | CN1721535A Human secreted protein hZG16 |
| 01/18/2006 | CN1721534A Human secreted protein hPAP21 |
| 01/18/2006 | CN1721533A Fusion protein of IL2 and single chain antibody against GD2, its encoding genes and use thereof |
| 01/18/2006 | CN1721528A Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721442A Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/18/2006 | CN1721441A Novel hepatic factor of human embryo |
| 01/18/2006 | CN1721440A Process for preparing thymosin |
| 01/18/2006 | CN1721439A Scylla serrata antibacterial peptide and its genes and clone method for genes |
| 01/18/2006 | CN1721438A Human secreted protein hCGI-143 |
| 01/18/2006 | CN1721437A Polypeptide antigen and antibody related to Tau protein |
| 01/18/2006 | CN1721436A Modified tumor antigen peptide and use thereof |
| 01/18/2006 | CN1721435A Tomato RNA virus host factor and genes encoding same and use thereof |
| 01/18/2006 | CN1721434A Novel protein, genes encoding the same and method of using the same |
| 01/18/2006 | CN1721433A Glycoprotein elicitor of magnaporthe grisea in rice leaves and its purification method |
| 01/18/2006 | CN1721432A Peptide specifically associated with front surface antigen zone of large protein of human hepatitis B virus surface antigen and uses thereof |
| 01/18/2006 | CN1237175C Protein production in transgenic alfalfa plants |
| 01/18/2006 | CN1237174C Temperature sensitive dtsR genes |
| 01/18/2006 | CN1237173C Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
| 01/18/2006 | CN1237172C Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method |
| 01/18/2006 | CN1237148C Use of alpha-1, 4-polyglucosanlyase in preparation of 1, 5-D-dehydrated fructose |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237074C Factor VIII separation |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1237072C Endothelial inhibin producing process |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/18/2006 | CN1236815C Application of integrin antagonists in preparation of medicine for treating multiple myeloma and myeloma-induced bone resorption |
| 01/17/2006 | US6987178 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 01/17/2006 | US6987176 Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization |
| 01/17/2006 | US6987173 Process for the preparation of active somatotropin from inclusion bodies |
| 01/17/2006 | US6987172 Multifunctional single chain glycoprotein hormones comprising three or more β subunits |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987167 Process for production of the somatostatin analog, octreotide |
| 01/17/2006 | US6987166 Anti-C5a antibodies |
| 01/17/2006 | US6987096 genetic engineering of a cyanovirin; gene therapy; exogenous gene expression; use alone or in combination with antiviral agents such as AZT; AIDS therapy |
| 01/17/2006 | US6987089 Mouse CIA protein and CIA gene having anti-apoptotic activity as a selective inhibitor of CAD interacting ASK1 use thereof |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987026 Vector for the transformation of Phaffia rhodozyma and process of transformation thereby |
| 01/17/2006 | US6987022 Lectin protein derived from Dolichos beans or soybeans; and a physiologically inert carrier material in the form of beads |
| 01/17/2006 | US6987020 Full-gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987004 Discovery of four mammalian genes designated CalDAG-GEFI, CalDAG-GEFII, cAMP-GEFI, and cAMP-GEFII, which encode proteins having a substrate specificity for Rap1A; dual binding domains for calcium and diacylglycerol; anticarcinogenic agents |
| 01/17/2006 | US6987003 Modulation of RNA transport to the rough endoplasmic reticulum by staufen proteins; isolated nucleic acids encoding this protein and vectors and host cells expressing them; nucleic acid sequences and their encoded amino acid sequences; viricides |
| 01/17/2006 | US6986997 Isolation of the organic anion transporter molecule(OAT) to enable a more precise analysis of renal ion exchanging relating drug releases; cultivating an oocyte to express the protein having an amino acid sequence of SEQ ID NO: 2 |
| 01/17/2006 | US6986994 INGAP displacement assays |
| 01/17/2006 | US6986990 Pollen allergy-related gene 513 |
| 01/17/2006 | US6986894 Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI) |
| 01/17/2006 | US6986893 Administering botulinum toxin in order to reduce mucus secretion of patient, wherein mucus secretion is not a symptom of rhinorrhea |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986887 Universal stem cells |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006004959A2 Pegylated interferon alpha-1b |
| 01/12/2006 | WO2006004675A2 Production of tissue factor in plants |
| 01/12/2006 | WO2006004287A1 Transgenic mice inducing alzheimer's disease expressing mutant app |
| 01/12/2006 | WO2006004244A1 Polypeptide having function of cinnamyl alcohol dehydrogenase, a polynucleotide coding the polypeptide and those uses |
| 01/12/2006 | WO2006004173A1 Viral particle-like construct and method of forming the same under physiological conditions |